[Allergy to local therapeutical association of nystatin, neomycin and triamcinolone acetonide].
D000293:Adolescent; D002675:Child, Preschool; D003877:Dermatitis, Contact / Q000139:chemically induced*; D003875:Drug Eruptions / Q000139:chemically induced*; D004342:Drug Hypersensitivity; D004485:Eczema / Q000188:drug therapy; D005029:Ethylenediamines / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D009355:Neomycin / Q000009:adverse effects*; D009761:Nystatin / Q000009:adverse effects*; D012882:Skin Tests; D014221:Triamcinolone / Q000009:adverse effects*
D005029:Ethylenediamines; D009761:Nystatin; D014221:Triamcinolone; D009355:Neomycin
L'allergie à l'association thérapeutique locale "nystatine, néomycine et acétonide de triamcinolone".